These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 27203162)

  • 1. [Investigation of the medical and social situation of patients managed by opiate replacement regimens for over 10 years by their GP].
    Messaadi N; Favre J; Rolland B; Cottencin O; Calafiore M; Stalnikiewicz B; Berkhout C
    Therapie; 2016 Oct; 71(5):439-446. PubMed ID: 27203162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013].
    Gentile G; Frauger E; Giocanti A; Pauly V; Orleans V; Amaslidou D; Thirion X; Micallef J;
    Therapie; 2016 Jun; 71(3):307-13. PubMed ID: 27235654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prescribing of methadone and other opioids to addicts: national survey of GPs in England and Wales.
    Strang J; Sheridan J; Hunt C; Kerr B; Gerada C; Pringle M
    Br J Gen Pract; 2005 Jun; 55(515):444-51. PubMed ID: 15970068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Reimbursement of opiate substitution drugs to militaries in 2007].
    d'Argouges F; Desjeux G; Marsan P; Thevenin-Garron V
    Encephale; 2012 Sep; 38(4):304-9. PubMed ID: 22980471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
    Duburcq A; Charpak Y; Blin P; Madec L
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does prescribing for opiate addiction change after national guidelines? Methadone and buprenorphine prescribing to opiate addicts by general practitioners and hospital doctors in England, 1995-2005.
    Strang J; Manning V; Mayet S; Ridge G; Best D; Sheridan J
    Addiction; 2007 May; 102(5):761-70. PubMed ID: 17506153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
    Fhima A; Henrion R; Lowenstein W; Charpak Y
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of opiate use disorders in France: results of an observational survey of general practitioners.
    Poloméni P; Bronner C; Fry F; Ravoninjatovo B; Fatseas M
    Addict Sci Clin Pract; 2015 Jun; 10():16. PubMed ID: 26117831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: methadone and Suboxone (buprenorphine-naloxone) patients compared.
    McKeganey N; Russell C; Cockayne L
    J Subst Abuse Treat; 2013 Jan; 44(1):97-102. PubMed ID: 22703715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are patients' pejorative representations of buprenorphine associated with their level of addiction and of misuse?
    Vanderkam P; Gagey S; Ingrand P; Perault-Pochat MC; Brabant Y; Blanchard C; Tudrej B; Messaadi N; Binder P
    Drug Alcohol Depend; 2018 Jul; 188():10-15. PubMed ID: 29727755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with work and taking prescribed methadone or buprenorphine among Swedish opiate addicts.
    Blom Nilsson M; Chassler D; Lundgren LM
    Eval Program Plann; 2015 Apr; 49():172-7. PubMed ID: 25624097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Buprenorphine/naloxone versus methadone in opioid dependence: a longitudinal survey.
    Curcio F; Franco T; Topa M; Baldassarre C;
    Eur Rev Med Pharmacol Sci; 2011 Aug; 15(8):871-4. PubMed ID: 21845796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to overcome hurdles in opiate substitution treatment? A qualitative study with general practitioners in Belgium.
    Fraeyman J; Symons L; Van Royen P; Van Hal G; Peremans L
    Eur J Gen Pract; 2016 Jun; 22(2):134-40. PubMed ID: 26799738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic evaluation: a comparison of methadone versus buprenorphine for opiate substitution treatment.
    Maas J; Barton G; Maskrey V; Pinto H; Holland R
    Drug Alcohol Depend; 2013 Dec; 133(2):494-501. PubMed ID: 23962419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methadone and buprenorphine prescribing patterns of Victorian general practitioners: their first 5 years after authorisation.
    Longman C; Lintzeris N; Temple-Smith M; Gilchrist G
    Drug Alcohol Rev; 2011 Jul; 30(4):355-9. PubMed ID: 21355929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [General practitioner views on drug-assisted rehabilitation and the Norwegian substance abuse reform].
    Aasland OG; Spilhaug G; Johannesen A
    Tidsskr Nor Laegeforen; 2009 Jan; 129(2):97-100. PubMed ID: 19151800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
    Johnson B; Richert T
    Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Evaluation of Inpatient Transfer from High-Dose Methadone to Buprenorphine Substitution Therapy.
    Oretti R
    J Subst Abuse Treat; 2015 Oct; 57():102-5. PubMed ID: 26048187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analgesic management of acute pain in patients receiving methadone or buprenorphine].
    Zinck L; Sonne NM; Madsen SL; Nikolajsen L
    Ugeskr Laeger; 2015 Mar; 177(10):. PubMed ID: 25749118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.